Personal pages menu

Articles

  1. Bakran I, Vrhovac B, Francetić I. The characteristics of clinical pharmacological articles in our medical journals. Liječ Vjesn 1975;97:711-4. (Cr*).
  2. Bešić J, Grims M, Fuks Ž, Beus I, Rulnjević J, Gjuriš V, Vrhovac B. Plasma concentrations of diazepam and its metabolites in tetanus therapy. Acta Pharm Jugoslav 1976;26:107-15
  3. Beus J, Rulnjević J, Vrhovac B, Gjuriš V, Bešić J, Grims M. Diazepam in the treatment of tetanus and its vestibulotoxicity. Liječ Vjesn 1976;98:317-32. (Cr).
  4. Mihovilović M, Bohaček N, Vrhovac B, Gjuriš V. Side effects of prophylactic treatment of bipolar disorder with lithium carbonate (correlation with its plasma concentration). Liječ Vjesn 1976;98:379-84. (Cr).
  5. Vrhovac B, Bakran I, Duraković Z, Gjurašin M, Francetić I, Mohaček I. The effect of propranolol, pindolol, practolol and verapamil versus placebo on exercise induced tachycardia in patients with ventricular preexcitation. Int J Clin Pharmacol 1976;14:132-43
  6. Bakran I, Koršić M, Duraković Z, Vrhovac B, Tajić M. The effect of alternate-day prednisone therapy on cortisol secretion rate in corticosteroid dependent asthmatics. Int J Clin Pharmacol 1977;15:57-60
  7. Bakran I, Koršić M, Duraković Z, Vrhovac B, Gjurašin M, Tajić M. Cortisol secreation rate during beclomethasone dipropionate aerosol therapy in bronchial asthma. Int J Clin Pharmacol 1977;15:13-5
  8. Profozić V, Vrhovac B, Francetić I, Bakran I, Gjurašin M. Drug consumption in the sample of medical patients. Liječ Vjesn 1977;99:761-7. (Cr).
  9. Vrhovac B, Brinar V, Tambić T, Gjuriš V, Barac B, Subotić R, Gjurašin M. Correlation of plasma gentamicin levels and its vestibulotoxicity. Acta Med Iug 1977;31:21-31. (Cr).
  10. Plavšić F, Vrhovac B, Bakran I, Gjurašin M, Goldner V. Direct measurement of digoxin level in plasma, saliva and urin by the radioimmunochemical method. Liječ Vjesn 1978;100:510-3. (Cr).
  11. Plavšić F, Vrhovac B, Bakran I. Determination of bioavailability of two oral theophylline preparations. Liječ Vjesn 1978;10:610-2. (Cr).
  12. Zlatić S, Skupnjak B, Hadži-Mustafić J, Lazar-Kajtas A, Havelka B, Granovi I, Holešek K, Balvanović F, Vrhovac B, Bakran I, Vujišević B, Huković S. Some sociomedical aspects of drug prescribing in Bosnia and Herzegovina. Pharmaca 1978;16:299-314. (Cr).
  13. Duraković Z, Čulig J, Vrhovac B, Plavšić F. Is there a correlation of quantitative changes in ECG and digoxin plasma level? Srp Arh Celok Lek 1979;107:1055-61. (Cr).
  14. Duraković Z, Vrhovac B, Fališevac V, Gjurašin M. Clinical therapeutic trial of cimetidine in erosive gastritis. Liječ Vjesn 1979;289-93. (Cr).
  15. Marinković M, Vrhovac B, Kuzmanić D, Radonić M. Comparative study with prazosin, methyldopa and polythiazide in arterial hypertension. Int J Clin Pharmacol Biopharm 1979;17:38-47
  16. Bakran I, Vrhovac B, Plavšić F. Aminophylline vs. salbutamol in exercise induced asthma. Int J Clin Pharmacol Ther Tox 1980;442-6
  17. Duraković Z, Vrhovac B, Plavšić F. The relation of clinical picture ECG and plasma digoxin levels. Liječ Vjesn 1980;102:567-70. (Cr).
  18. Duraković Z, Vrhovac B, Plavšić F. High digitalis plasma levels and ECG. Saopćenja 1980;26:185-94. (Cr).
  19. Kopitar Z, Milovac J, Vrhovac B, Tadjer I. Comparison of the bioavailability of Redergin tablets (1,0 mg) and Redergin solution. Int J Clin Pharmacol Ther Tox 1981;20:134-8
  20. Kopitar Z, Cvelbar P, Vrhovac B, Grims M. Bioavailability of two cimetidine tablet formulations. Pharmaca 1981;19:33-9. (Cr).
  21. Plavšić F, Vrhovac B. Investigation of talampicillin and ampicillin pharmacokinetics. Liječ Vjesn 1981;103:83-6. (Cr).
  22. Plavšić F, Vrhovac B, Bakran I, Čulig J. The importance of the way and place of blood sample taking for determination of acid base balance and hemoglobin oxigen saturation. Liječ Vjesn 1981;102:527-9. (Cr).
  23. Plavšić F, Vrhovac B, Radošević A, Dvoržak I. Correlation between fluorimetric and microbiological methods for determination of cephalexin in urine and serum. J Clin Chem Clin Biochem 1981;19:35-8
  24. Plavšić F, Čulig J, Bakran I, Vrhovac B. Teophylline concentration in saliva as a guide for individualization of its therapeutic use. Br J Clin Pharmacol 1981;11:533-4
  25. Plavšić F, Vrhovac B, Stavljenić A. Determination of bioequivalence of two oral iron preparation. Pharmaca 1982;20:219-26
  26. Cvelbar P, Lenardič A, Kopitar Z, Vrhovac B, Plavšić F. Bioequivalence of two medical products of pipemidic acid. Chemother 1983;2(suppl.I):239-40
  27. Francetić I, Plavšić F, Vrhovac B. The bioavailability and biological equivalence of penicillin antibiotics. Chemother 1983;2(suppl.I):202-5
  28. Plavšić F, Vrhovac B, Čulig J. Biological equivalence of two oral iron preparations. Jug Physiol Pharm Acta 1983;(suppl.2):303-4
  29. Duraković Z, Vrhovac B, Plavšić F. Electrocardiogram and high plasma digoxin concentration. Int J Clin Pharmacol Therap Tox 1984;22:45-7
  30. Kopitar Z, Cvelbar P, Vrhovac B, Lenardič A, Žorž M. Determination of bioavailability of two pipemidic acid preparations in volunteers. Zdrav Vestnik 1984;53:57-60. (Slo).
  31. Fališevac V, Vucelić B, Vrhovac B, i sur. Multicentric comparative investigation of sucralphate and cimetidine in the treatment of ventricular and duodenal ulcer disease. Liječ Vjesn 1985;107:23-6. (Cr).
  32. Spagnoli A, Tognoni G, Darmanasjah I, Laporte JR, Vrhovac B, Treacher DF, Warlow CP. A multinational comparison of drug treatment in patients with cerebrovascular disease. Europ Neurol 1985;24:4-12
  33. Vrhovac B. Critical analysis of drugs approved in Yugoslavia in the period of 1970-1985. Pharmaca 1985;23:265-76. (Cr).
  34. Gašparović V, Vrhovac B, Rumboldt Z, Ivanković D. Comparative clinical investigation of the antihypertensive effect of uropidil vs diazoxide in patients with severe aarterial hypertension. Liječ Vjesn 1986;108:494-6. (Cr).
  35. Kopitar Z, Vrhovac B, Lenardič A, Cvelbar P, Žorž M, Francetić I. Dose dependent bioavailability of propranolol. J Clin Pharmacol Ther Tox 1986;24:319-22
  36. Vucelić B, Fališevac V, Vrhovac B, Elaković M, Bjelić J, Kostić M, Vučemilo M, Mohorić I, Prica M. Multicentric comparative clinical trial of ranitidine vs cimetidine in the treatemnt of duodenal ulcer. Liječ Vjesn 1986;108:314-7. (Cr).
  37. Wolf-Čoporda A, Plavšić F, Vrhovac B. Determination of biological equivalence of two atenolol preparations. Int J Clin Pharmacol Ther Tox 1987;25:567-71
  38. Hadžić N, Vrhovac B, Popović O, i sur. Famotidine (40 mg in the evening) vs ranitidine (2 x 150 mg) in the acute treatment of ventricular and duodenal ulcer disease. Gastroenterohep Arh 1988;7.53-9. (Cr).
  39. Wolf-Čoporda A, Vrhovac B, Manojlović Z, Plavšić F. Determination of bioequivalence of two oral metoclopramide preparations. Acta Pharm Jugosl 1988;38:213-21
  40. Čirko-Begović N, Vrhovac B, Bakran I. Intensive monitoring of adverse drug reactions in infants and preschool children. Eur J Clin Pharmacol 1989;36:63-5
  41. Domljan Z, Vrhovac B, Durrigl T, Pučar I. A double blind trial of ademetionine vs. naproxen in activated arthrosis. Int J Clin Pharmacol Ther Tox 1989;27:329-33
  42. Gašparović V, Puretić Z, Vrhovac B, Gjurašin M, Puljević D. Recombinant erythropoietin in the treatment of anemia of end stage reanal disease. Mak Med pregled 1989;43(suppl 9):429-30. (Cr).
  43. Gašparović V, Vrhovac B, Ivanović D, Rumboldt Z, Gjurašin M, Ivanković D. Urapidil vs. diazoxide in patients with malignant hypertension or hypertensive crisis. Acta Pharm Jugosl 1989;39:219-24
  44. Plavšić F, Wolf-Čoporda A, Vrhovac B, Alebić-Kolbah T. Absolute bioavailability and pharmacokinetics of four ampicillin preparations from two bioequivalence studies in healthy volunteers. Acta Pharm Jugosl 1989;39:53-61
  45. Pulanić R, Vrhovac B, Jereb B, Jokić N. Controlled trial of prophylactic administration of antibiotics in sclerotherapy of esophageal varices. J Chemoth 1989;1:261-6
  46. Kopitar Z, Vrhovac B, Povšič L, Plavšić F, Francetić I. The effect of food and metoclopramide on the pharmacokinetics and side effects of bromocriptine. Eur J Drug Metab Pharmacokinet 1991;16:177-81
  47. Pulanić R, Vrhovac B, Jokić N, Rosandić-Pilaš M, Šalamon V, Opačić M, Rustemović N, Korać B, Vucelić B. Prophylactic administration of ranitidine after sclerotherapy of esophageal varices. Int J Clin Pharmacol Ther Tox 1991;29:347-51
  48. Macolić V, Vrhovac B. Pharmacokinetics and interactions of digoxin, theophylline and furosemide in disease with edema. Int J Clin Pharmacol Ther Tox 1993;31:6-11
  49. Manojlović Z, Vrhovac B, Manojlović S. Qualitative analysis of drug prescription in a geriatric population sample. Int J Clin Pharmacol Ther Tox 1993;31:430-434.
  50. Miličević G, Planinc D, Planinc-Perajica A, Vrhovac B. A high incidence of tolerance to hypotensive effect of low nitroglycerine dose detected by cyclic interruption of a nitroglycerin infusion. CMJ 1993;34:60-5
  51. Miličević G, Vrhovac B, Planinc D. A dynamical model for separation of secondary resistance from tolerance to nitroglycerin infusion. Int J Clin Pharmacol Ther Tox 1993;31:12-7
  52. Huić M, Macolić V, Vrhovac B, Francetić I, Bakran I, Giljanović S: Adverse drug reactions resulting in hospital admission. Int J Clin Pharmacol. Ther. 1994: 32:675-682.
  53. Bakran I, Macolić-Šarinić V, Plavšić F, Vrhovac B, Francetić I. Theophylline pharmacokinetics in edema. Acta Pharm 1995; 45: 499-502
  54. Macolić-Šarinić V, Vrhovac B, Plavšić F, Huić M, Bakran I, Francetić I, Giljanović S, Sarapa N. Pharmacokinetics of intravenously administered digoxin in patients with edema. Acta Pharm 1995; 45:7-14
  55. Plavšić F, Wolf-Čoporda A, Bilušić M, Lovrić Z, Macolić-Šarinić V, Puretić Z, Bubić-Filipi Lj, Vrhovac B. Bioequivalence of two oral cyclosporine preparations. Drug Res 1995; 45:914
  56. Vrhovac B, Sarapa N, Bakran I, Huić M, Macolić-Šarinić V, Francetić I, Čoporda-Wolf A., Plavšić F. Pharmacokinetic changes in patients with oedema. Clin Pharmacokin 1995; 28:405-18
  57. Huić M, Vrhovac B, Macolić-Šarinić M, Francetić I, Bakran I, Giljanović S. How safe are bioequuivalence studies in healthy volunteers? Therapie 1996;51:410-3.